524212 Stock Overview Manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Wanbury Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Wanbury Historical stock prices Current Share Price ₹305.30 52 Week High ₹325.00 52 Week Low ₹122.10 Beta 0.65 1 Month Change 38.77% 3 Month Change 15.64% 1 Year Change 131.29% 3 Year Change 281.15% 5 Year Change 1,545.82% Change since IPO 63.83%
Recent News & Updates
New minor risk - Share price stability Dec 11
Wanbury Limited Announces Retirement of Pravin Dilip Pawar as Independent Director Dec 06
Investor sentiment improves as stock rises 16% Dec 02
Pravin Dilip Pawar Retires from the Position of the Independent Directors on Completion of First Term of Office as an Independent Director of Wanbury Limited Nov 21
Second quarter 2025 earnings released: EPS: ₹2.44 (vs ₹2.25 in 2Q 2024) Nov 18
Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024 Nov 06 See more updates
New minor risk - Share price stability Dec 11
Wanbury Limited Announces Retirement of Pravin Dilip Pawar as Independent Director Dec 06
Investor sentiment improves as stock rises 16% Dec 02
Pravin Dilip Pawar Retires from the Position of the Independent Directors on Completion of First Term of Office as an Independent Director of Wanbury Limited Nov 21
Second quarter 2025 earnings released: EPS: ₹2.44 (vs ₹2.25 in 2Q 2024) Nov 18
Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024 Nov 06
Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024 Nov 05
Investor sentiment improves as stock rises 16% Sep 16 Wanbury Limited Informs About Its New Products Launch Sep 12
Wanbury Limited, Annual General Meeting, Sep 27, 2024 Aug 30
Wanbury Limited Announces Appointment of Pradeep Patni as CEO of India Formulation Business Aug 22
Investor sentiment improves as stock rises 18% Aug 22
First quarter 2025 earnings released: EPS: ₹0.32 (vs ₹1.43 in 1Q 2024) Aug 13
Wanbury Limited to Report Q1, 2025 Results on Aug 12, 2024 Aug 06
Investor sentiment improves as stock rises 20% Jul 15
Full year 2024 earnings released: EPS: ₹17.10 (vs ₹3.18 loss in FY 2023) May 18
Investor sentiment improves as stock rises 15% May 17
Wanbury Limited to Report Q4, 2024 Results on May 16, 2024 May 09
Less than half of directors are independent Apr 12
Investor sentiment improves as stock rises 15% Apr 03
Investor sentiment deteriorates as stock falls 18% Mar 15
Wanbury Limited Announces Retirement of Pallavi Prakash Shedge as Independent Director Feb 21
Third quarter 2024 earnings released: EPS: ₹3.14 (vs ₹1.00 loss in 3Q 2023) Jan 25
Wanbury Limited to Report Q3, 2024 Results on Jan 24, 2024 Jan 13
Wanbury Limited Approves Appointment of Pravin Dilip Pawar as the Non-Executive Independent Director Nov 19
Second quarter 2024 earnings released: EPS: ₹2.25 (vs ₹0.27 loss in 2Q 2023) Oct 21
Wanbury Limited to Report Q2, 2024 Results on Oct 20, 2023 Oct 13
New major risk - Negative shareholders equity Sep 11
Wanbury Limited, Annual General Meeting, Sep 27, 2023 Aug 31
Wanbury Limited Appoints Mohan Kumar Rayana as Whole Time Director Aug 22
First quarter 2024 earnings released: EPS: ₹1.43 (vs ₹2.22 loss in 1Q 2023) Aug 12
Wanbury Limited to Report Q1, 2024 Results on Aug 11, 2023 Aug 03
Full year 2023 earnings released: ₹3.18 loss per share (vs ₹25.29 profit in FY 2022) Jul 08
Wanbury Limited to Report Q4, 2023 Results on Jun 26, 2023 Jun 09
Investor sentiment improves as stock rises 20% Jun 05
Wanbury Limited to Report Q4, 2023 Results on May 30, 2023 May 23
Investor sentiment improves as stock rises 27% Apr 25
Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹0.12 profit in 3Q 2022) Feb 16
Wanbury Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 04
Second quarter 2023 earnings released: ₹0.27 loss per share (vs ₹0.17 loss in 2Q 2022) Nov 30
Investor sentiment deteriorated over the past week Nov 21
Wanbury Limited to Report Q2, 2023 Results on Nov 11, 2022 Oct 30
Investor sentiment improved over the past week Sep 09
Wanbury Limited, Annual General Meeting, Sep 28, 2022 Aug 31
First quarter 2023 earnings released: ₹2.22 loss per share (vs ₹0.28 loss in 1Q 2022) Aug 12
Investor sentiment improved over the past week Aug 05
Wanbury Limited to Report Q1, 2023 Results on Aug 10, 2022 Jul 30
Investor sentiment improved over the past week Jun 29
Full year 2022 earnings released: EPS: ₹25.29 (vs ₹5.04 loss in FY 2021) Jun 24
Wanbury Limited to Report Q4, 2022 Results on Jun 22, 2022 May 21 Wanbury Limited announced that it expects to receive INR 143.0625 million in funding from Expert Chemicals (India) Pvt. Ltd. Feb 18
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 10
Wanbury Limited to Report Q3, 2022 Results on Feb 08, 2022 Feb 03
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Nov 28
First quarter 2022 earnings released: ₹0.28 loss per share (vs ₹4.47 loss in 1Q 2021) Oct 22
Full year 2021 earnings released: ₹5.04 loss per share (vs ₹26.90 profit in FY 2020) Jul 01
Investor sentiment improved over the past week Apr 29
Wanbury Limited announced that it has received INR 494.999765 million in funding from Bakliwal Fincom Pvt Ltd, Radhakrishna Ramnarain Private Limited, Niche Financial Services Pvt. Ltd, Vidyut Merchandise Pvt Ltd, Dalal & Broacha Stock Broking Pvt Ltd., Asset Management Arm and other investors Apr 24
Investor sentiment improved over the past week Apr 10
New 90-day high: ₹94.70 Feb 25
Investor sentiment improved over the past week Feb 19
Third quarter 2021 earnings released: EPS ₹2.36 (vs ₹0.90 loss in 3Q 2020) Feb 15
Wanbury Limited Approves Board Appointments Feb 07
Wanbury Limited to Report Q3, 2021 Results on Feb 12, 2021 Feb 05
New 90-day high: ₹60.60 Jan 28
Investor sentiment improved over the past week Jan 01
New 90-day high: ₹43.85 Dec 30
New 90-day high: ₹38.10 Dec 07
Wanbury Limited to Report Q2, 2021 Results on Nov 12, 2020 Oct 31
Wanbury Limited to Report Q1, 2021 Results on Sep 11, 2020 Aug 29
New 90-day high - ₹33.95 Aug 05
Wanbury Limited to Report Q4, 2020 Final Results on Jul 22, 2020 Jul 17 Shareholder Returns 524212 IN Pharmaceuticals IN Market 7D -5.2% -1.0% -0.9% 1Y 131.3% 39.2% 22.5%
See full shareholder returns
Return vs Market: 524212 exceeded the Indian Market which returned 22.5% over the past year.
Price Volatility Is 524212's price volatile compared to industry and market? 524212 volatility 524212 Average Weekly Movement 7.8% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 524212's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524212's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas.
Show more Wanbury Limited Fundamentals Summary How do Wanbury's earnings and revenue compare to its market cap? 524212 fundamental statistics Market cap ₹10.53b Earnings (TTM ) ₹529.62m Revenue (TTM ) ₹5.77b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 524212 income statement (TTM ) Revenue ₹5.77b Cost of Revenue ₹2.94b Gross Profit ₹2.83b Other Expenses ₹2.30b Earnings ₹529.62m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 16.17 Gross Margin 49.08% Net Profit Margin 9.18% Debt/Equity Ratio 453.1%
How did 524212 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/18 15:36 End of Day Share Price 2024/12/18 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Wanbury Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
